Catalent Pharma Solutions, a drug delivery and dosage forms specialist, has hired Stephen Vanni as General Manager of the firm’s Braeside facility in Melbourne, Australia.
This 331,055 ft2 (approximately 31,000 m2) facility is one of Catalent’s key strategic hubs within the Asia Pacific region, and has both softgel and solid dose manufacturing operations.
Vanni joins Catalent from Aspen Pharma, where he was Southern Region Plant Manager, based at the company’s Dandenong facility, and had full responsibility over the plant’s safety, quality and regulatory compliance, as well financial oversight on investment and revenue.
'Stephen will play a central role in the strategic growth of Catalent’s business within Australia and the greater Asia-Pacific region,' said Mark Bisset, President of Catalent Asia Pacific.
Vanni has more than 20 years’ experience within the chemical and food production industries, and has previously worked for ICI Australia and Bristol-Myers Squibb. He holds a MSc in Chemistry from Monash University, Melbourne.
In 2015, Catalent acquired a facility in Cromer, New South Wales, from PharmaPak, to offer primary and secondary packaging of oral pharmaceutical dose forms. This facility, alongside Braeside, supports Catalent’s integrated supply to customers across Australia, New Zealand and the Asia Pacific region.
